Detection of human herpesvirus 7 DNA in peripheral blood reflects mainly CD4+ cell count in patients infected with HIV

Authors

  • David Boutolleau,

    Corresponding author
    1. Laboratoire de Virologie, UPRES EA 2387, Groupe Hospitalier Pitié-Salpêtrière, Paris, France
    2. Laboratoire de Bactériologie-Virologie, Faculté de Médecine Paris Sud, CHU de Bicêtre, Le Kremlin-Bicêtre, France
    • Laboratoire de Virologie, UPRES EA 2387, Groupe Hospitalier Pitié-Salpêtrière, 83 boulevard de l'Hôpital, 75013 Paris, France.
    Search for more papers by this author
  • Olivia Bonduelle,

    1. Laboratoire d'Immunologie Cellulaire et Tissulaire, INSERM U543, Groupe Hospitalier Pitié-Salpêtrière, Paris, France
    Search for more papers by this author
  • Amélie Sabard,

    1. Laboratoire de Virologie, UPRES EA 2387, Groupe Hospitalier Pitié-Salpêtrière, Paris, France
    Search for more papers by this author
  • Laure Devers,

    1. Site Transfusionnel, Groupe Hospitalier Pitié-Salpêtrière, Paris, France
    Search for more papers by this author
  • Henri Agut,

    1. Laboratoire de Virologie, UPRES EA 2387, Groupe Hospitalier Pitié-Salpêtrière, Paris, France
    Search for more papers by this author
  • Agnès Gautheret-Dejean

    1. Laboratoire de Virologie, UPRES EA 2387, Groupe Hospitalier Pitié-Salpêtrière, Paris, France
    2. Laboratoire de Microbiologie, Faculté des Sciences Pharmaceutiques et Biologiques, Paris, France
    Search for more papers by this author

Abstract

The opportunistic behavior and the potential interactions of human herpesvirus 7 (HHV-7) with human immunodeficiency virus (HIV)-1 in HIV-1-infected patients were investigated in comparison with HHV-6, another human roseolovirus. Roseolovirus DNAs were detected and quantified in peripheral blood mononuclear cells (PBMCs) from 198 HIV-seronegative healthy blood donors, 38 HIV-1-infected patients classified as long-term non-progressors, and 99 HIV-1-infected patients classified as progressors. The rate of HHV-7 DNA detection was higher in healthy donors (78%) than in long-term non-progressors (47%; P = 0.0003) or in progressors (52%; P < 0.0001). HHV-7 cell load was higher in healthy donors (median: 212 EqCop/106 PBMCs) and in long-term non-progressors (median: 105 EqCop/106 PBMCs) than in progressors (median: 48 EqCop/106 PBMCs; P < 0.0001 and P = 0.015, respectively). Among progressors, HHV-7 detection was correlated positively with the CD4+ T-lymphocyte count (P = 0.028). Neither HHV-7 detection rate nor cell load was correlated with the HIV-1 plasma load. As a whole, HHV-6 detection rate and cell load were lower than the HHV-7 counterparts, albeit exhibiting similar differences between healthy donors, long-term non-progressors, and progressors. In conclusion, HHV-7 infection does not appear to be stimulated by HIV-1 infection, nor interact with it. Rather, HHV-7 detection rate and cell load reflect CD4+ T-lymphocyte count, with higher values in healthy donors and long-term non-progressors than in progressors. J. Med. Virol. 76:223–228, 2005. © 2005 Wiley-Liss, Inc.

Ancillary